<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39162510</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>04</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>05</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2165-0497</ISSN><JournalIssue CitedMedium="Internet"><Volume>12</Volume><Issue>10</Issue><PubDate><Year>2024</Year><Month>Oct</Month><Day>03</Day></PubDate></JournalIssue><Title>Microbiology spectrum</Title><ISOAbbreviation>Microbiol Spectr</ISOAbbreviation></Journal><ArticleTitle>Respiratory virus disease and outcomes at a large academic medical center in the United States: a retrospective observational study of the early 2023/2024 respiratory viral season.</ArticleTitle><Pagination><StartPage>e0111624</StartPage><MedlinePgn>e0111624</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e01116-24</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1128/spectrum.01116-24</ELocationID><Abstract><AbstractText>Respiratory disease, attributed to influenza, respiratory syncytial virus (RSV), and SARS-CoV-2, was reported nationally during the 2023/2024 respiratory viral season. The emergence of novel SARS-CoV-2 variants was considered a significant factor contributing to the rise in COVID-19 cases. Data from the Johns Hopkins Hospital System (JHHS) showed that enterovirus/rhinovirus had also been circulating at high rates. Analyzing clinical outcomes of the most prevalent respiratory viruses is crucial for understanding the role of circulating viral genotypes. A retrospective cohort of patients who tested positive for SARS-CoV-2, influenza, RSV, or enterovirus/rhinovirus between 1 June and 31 December 2023 was included in the study. Remnant clinical samples were utilized for targeted viral whole-genome sequencing and genotyping. Patients' metadata and outcomes following infection were studied, stratified by viral variants and genotypes. The increase of SARS-CoV-2 positivity in December was associated with the predominance of JN.1. Admissions for patients under 18 years old were primarily associated with enterovirus/rhinovirus and RSV, while older age groups were mainly linked to SARS-CoV-2 and influenza infections. SARS-CoV-2-related admissions increased with the predominance of the JN.1 variant in December. No significant difference in admissions for influenza subtypes, rhinovirus species, or SARS-CoV-2 variants was observed. RSV A was associated with slightly higher odds of admission compared with RSV B. Our data highlight the importance of systematically analyzing respiratory viral infections to inform public health strategies and clinical management, especially as SARS-CoV-2 becomes endemic. The findings highlight the value of expanded genomic surveillance in elucidating the clinical significance of viral evolution.IMPORTANCEThe analysis of the epidemiology and clinical outcomes of multiple co-circulating respiratory viruses in the early 2023/2024 respiratory virus season highlights the emergence of the SARS-CoV-2 JN.1 variant as well as underscores the importance of enterovirus/rhinovirus in respiratory infections. Understanding these dynamics is essential for refining public health strategies and clinical management, especially as SARS-CoV-2 transitions to an endemic status. This work emphasizes the need for ongoing surveillance, robust diagnostic algorithms, and detailed genomic analyses to anticipate and mitigate the burden of respiratory viral infections, ultimately contributing to more informed decision-making in healthcare settings and better patient outcomes.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mostafa</LastName><ForeName>Heba H</ForeName><Initials>HH</Initials><Identifier Source="ORCID">0000-0002-0274-8966</Identifier><AffiliationInfo><Affiliation>Department of Pathology, Division of Medical Microbiology, Johns Hopkins School of Medicine, Baltimore, Maryland, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fall</LastName><ForeName>Amary</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Pathology, Division of Medical Microbiology, Johns Hopkins School of Medicine, Baltimore, Maryland, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Norton</LastName><ForeName>Julie M</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Department of Pathology, Division of Medical Microbiology, Johns Hopkins School of Medicine, Baltimore, Maryland, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sachithanandham</LastName><ForeName>Jaiprasath</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>W. Harry Feinstone Department of Molecular Microbiology and Immunology, The Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yunker</LastName><ForeName>Madeline</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Pathology, Division of Medical Microbiology, Johns Hopkins School of Medicine, Baltimore, Maryland, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abdullah</LastName><ForeName>Omar</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Department of Pathology, Division of Medical Microbiology, Johns Hopkins School of Medicine, Baltimore, Maryland, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hanlon</LastName><ForeName>Ann</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Pathology, Division of Medical Microbiology, Johns Hopkins School of Medicine, Baltimore, Maryland, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gluck</LastName><ForeName>Linda</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Pathology, Division of Medical Microbiology, Johns Hopkins School of Medicine, Baltimore, Maryland, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morris</LastName><ForeName>C Paul</ForeName><Initials>CP</Initials><AffiliationInfo><Affiliation>Integrated Research Facility, Division of Clinical Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Frederick, Maryland, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pekosz</LastName><ForeName>Andrew</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0003-3248-1761</Identifier><AffiliationInfo><Affiliation>W. Harry Feinstone Department of Molecular Microbiology and Immunology, The Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Emergency Medicine, Johns Hopkins School of Medicine, Baltimore, Maryland, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Klein</LastName><ForeName>Eili Y</ForeName><Initials>EY</Initials><Identifier Source="ORCID">0000-0002-1304-5289</Identifier><AffiliationInfo><Affiliation>Department of Emergency Medicine, Johns Hopkins School of Medicine, Baltimore, Maryland, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Disease Dynamics, Economics, and Policy, Washington, DC, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>HHSN272201400007C</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 DA045556</GrantID><Acronym>DA</Acronym><Agency>NIDA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 CK000589</GrantID><Acronym>CK</Acronym><Agency>NCEZID CDC HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U54 HL143541</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>08</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Microbiol Spectr</MedlineTA><NlmUniqueID>101634614</NlmUniqueID><ISSNLinking>2165-0497</ISSNLinking></MedlineJournalInfo><SupplMeshList><SupplMeshName Type="Organism" UI="C000711908">SARS-CoV-2 variants</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000046" MajorTopicYN="Y">Academic Medical Centers</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012141" MajorTopicYN="Y">Respiratory Tract Infections</DescriptorName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004770" MajorTopicYN="N">Enterovirus</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName><QualifierName UI="Q000145" MajorTopicYN="N">classification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007251" MajorTopicYN="N">Influenza, Human</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018357" MajorTopicYN="N">Respiratory Syncytial Virus Infections</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012621" MajorTopicYN="N">Seasons</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012229" MajorTopicYN="N">Rhinovirus</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName><QualifierName UI="Q000145" MajorTopicYN="N">classification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007231" MajorTopicYN="N">Infant, Newborn</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006760" MajorTopicYN="N">Hospitalization</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005838" MajorTopicYN="N">Genotype</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">enterovirus</Keyword><Keyword MajorTopicYN="N">genome analysis</Keyword><Keyword MajorTopicYN="N">influenza</Keyword><Keyword MajorTopicYN="N">respiratory syncytial virus</Keyword><Keyword MajorTopicYN="N">rhinovirus</Keyword></KeywordList><CoiStatement>H.H.M. reports research collaborations with Hologic, Bio-Rad, and DiaSorin. H.H.M. serves as an advisor for BD Diagnostics and on the advisory board of Seegene. H.H.M. received honoraria from BD Diagnostics and Bio-Rad.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>4</Day><Hour>12</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>8</Month><Day>20</Day><Hour>12</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>8</Month><Day>20</Day><Hour>9</Hour><Minute>13</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>8</Month><Day>20</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39162510</ArticleId><ArticleId IdType="pmc">PMC11448398</ArticleId><ArticleId IdType="doi">10.1128/spectrum.01116-24</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Available from: https://www.cdc.gov/forecast-outbreak-analytics/about/season-outlook.html. Retrieved
8 Feb 2024.</Citation></Reference><Reference><Citation>Rubin R. 2024. As COVID-19 cases surge, here’s what to know about JN.1, the latest SARS-CoV-2 “variant of interest.” JAMA 331:382–383. doi:10.1001/jama.2023.27841</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2023.27841</ArticleId><ArticleId IdType="pubmed">38214935</ArticleId></ArticleIdList></Reference><Reference><Citation>Fall A, Han L, Yunker M, Gong YN, Li TJ, Norton JM, Abdullah O, Rothman RE, Fenstermacher KZJ, Morris CP, Pekosz A, Klein E, Mostafa HH. 2023. Evolution of influenza A(H3N2) viruses in 2 consecutive seasons of genomic surveillance, 2021-2023. Open Forum Infect Dis 10:fad577. doi:10.1093/ofid/ofad577</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofad577</ArticleId><ArticleId IdType="pmc">PMC10715682</ArticleId><ArticleId IdType="pubmed">38088981</ArticleId></ArticleIdList></Reference><Reference><Citation>
CDC . Available from: https://www.cdc.gov/flu/weekly/index.htm. Retrieved
25 Jan 2024.</Citation></Reference><Reference><Citation>Maltezou HC, Papanikolopoulou A, Vassiliu S, Theodoridou K, Nikolopoulou G, Sipsas NV. 2023. COVID-19 and respiratory virus co-infections: a systematic review of the literature. Viruses 15:865. doi:10.3390/v15040865</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v15040865</ArticleId><ArticleId IdType="pmc">PMC10142898</ArticleId><ArticleId IdType="pubmed">37112844</ArticleId></ArticleIdList></Reference><Reference><Citation>Uyeki TM, Bernstein HH, Bradley JS, Englund JA, File TM, Fry AM, Gravenstein S, Hayden FG, Harper SA, Hirshon JM, Ison MG, Johnston BL, Knight SL, McGeer A, Riley LE, Wolfe CR, Alexander PE, Pavia AT. 2019. Clinical practice guidelines by the infectious diseases society of America: 2018 update on diagnosis, treatment, chemoprophylaxis, and institutional outbreak management of seasonal influenzaa. Clin Infect Dis 68:e1–e47. doi:10.1093/cid/ciy866</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciy866</ArticleId><ArticleId IdType="pmc">PMC6653685</ArticleId><ArticleId IdType="pubmed">30566567</ArticleId></ArticleIdList></Reference><Reference><Citation>Mostafa HH, Lamson DM, Uhteg K, Geahr M, Gluck L, de Cárdenas JNB, Morehead E, Forman M, Carroll KC, Hayden RT, George KS. 2020. Multicenter evaluation of the NeuMoDx SARS-CoV-2 test. J Clin Virol 130:104583. doi:10.1016/j.jcv.2020.104583</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcv.2020.104583</ArticleId><ArticleId IdType="pmc">PMC7413157</ArticleId><ArticleId IdType="pubmed">32791382</ArticleId></ArticleIdList></Reference><Reference><Citation>Mostafa HH, Carroll KC, Hicken R, Berry GJ, Manji R, Smith E, Rakeman JL, Fowler RC, Leelawong M, Butler-Wu SM, Quintero D, Umali-Wilcox M, Kwiatkowski RW, Persing DH, Weir F, Loeffelholz MJ. 2021. Multi-center evaluation of the cepheid Xpert(R) xpress SARS-CoV-2/Flu/RSV Test. J Clin Microbiol 59. doi:10.1128/JCM.02955-20</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.02955-20</ArticleId><ArticleId IdType="pmc">PMC8106732</ArticleId><ArticleId IdType="pubmed">33298613</ArticleId></ArticleIdList></Reference><Reference><Citation>Jarrett J, Uhteg K, Forman MS, Hanlon A, Vargas C, Carroll KC, Valsamakis A, Mostafa HH. 2021. Clinical performance of the GenMark Dx ePlex respiratory pathogen panels for upper and lower respiratory tract infections. J Clin Virol 135:104737. doi:10.1016/j.jcv.2021.104737</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcv.2021.104737</ArticleId><ArticleId IdType="pubmed">33497932</ArticleId></ArticleIdList></Reference><Reference><Citation>Fall A, Eldesouki RE, Sachithanandham J, Morris CP, Norton JM, Gaston DC, Forman M, Abdullah O, Gallagher N, Li M, Swanson NJ, Pekosz A, Klein EY, Mostafa HH. 2022. The displacement of the SARS-CoV-2 variant Delta with omicron: an investigation of hospital admissions and upper respiratory viral loads. EBioMedicine 79:104008. doi:10.1016/j.ebiom.2022.104008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2022.104008</ArticleId><ArticleId IdType="pmc">PMC9020587</ArticleId><ArticleId IdType="pubmed">35460989</ArticleId></ArticleIdList></Reference><Reference><Citation>Tapparel C, Sobo K, Constant S, Huang S, Van Belle S, Kaiser L. 2013. Growth and characterization of different human rhinovirus C types in three-dimensional human airway epithelia reconstituted in vitro. Virology 446:1–8. doi:10.1016/j.virol.2013.06.031</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2013.06.031</ArticleId><ArticleId IdType="pubmed">24074561</ArticleId></ArticleIdList></Reference><Reference><Citation>Kroneman A, Vennema H, Deforche K, v d Avoort H, Peñaranda S, Oberste MS, Vinjé J, Koopmans M. 2011. An automated genotyping tool for enteroviruses and noroviruses. J Clin Virol 51:121–125. doi:10.1016/j.jcv.2011.03.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcv.2011.03.006</ArticleId><ArticleId IdType="pubmed">21514213</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang L, Ng TFF, Castro CJ, Marine RL, Magaña LC, Esona M, Peret TCT, Thornburg NJ. 2022. Next-generation sequencing of human respiratory syncytial virus subgroups A and B genomes. J Virol Methods 299:114335. doi:10.1016/j.jviromet.2021.114335</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jviromet.2021.114335</ArticleId><ArticleId IdType="pubmed">34673119</ArticleId></ArticleIdList></Reference><Reference><Citation>Morris CP, Eldesouki RE, Sachithanandham J, Fall A, Norton JM, Abdullah O, Gallagher N, Li M, Pekosz A, Klein EY, Mostafa HH. 2023. Omicron subvariants: clinical, laboratory, and cell culture characterization. Clin Infect Dis 76:1276–1284. doi:10.1093/cid/ciac885</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciac885</ArticleId><ArticleId IdType="pmc">PMC10069846</ArticleId><ArticleId IdType="pubmed">36366857</ArticleId></ArticleIdList></Reference><Reference><Citation>Dias CS, Diniz LM, Oliveira MCL, Simões E Silva AC, Colosimo EA, Mak RH, Pinhati CC, Galante SC, Veloso IY, Martelli-Júnior H, Oliveira EA. 2024. Outcomes of SARS-CoV-2 and seasonal viruses among children hospitalized in Brazil. Pediatrics 153:e2023064326. doi:10.1542/peds.2023-064326</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.2023-064326</ArticleId><ArticleId IdType="pubmed">38213278</ArticleId></ArticleIdList></Reference><Reference><Citation>Hedberg P, Abdel-Halim L, Valik JK, Alfvén T, Nauclér P. 2024. Outcomes of pediatric SARS-CoV-2 Omicron infection vs influenza and respiratory syncytial virus infections. JAMA Pediatr 178:197–199. doi:10.1001/jamapediatrics.2023.5734</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamapediatrics.2023.5734</ArticleId><ArticleId IdType="pmc">PMC10751651</ArticleId><ArticleId IdType="pubmed">38147325</ArticleId></ArticleIdList></Reference><Reference><Citation>Boon H, Meinders A-J, van Hannen EJ, Tersmette M, Schaftenaar E. 2024. Comparative analysis of mortality in patients admitted with an infection with influenza A/B virus, respiratory syncytial virus, rhinovirus, metapneumovirus or SARS-CoV-2. Influen Res Virus 18:e13237. doi:10.1111/irv.13237</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/irv.13237</ArticleId><ArticleId IdType="pmc">PMC10796251</ArticleId><ArticleId IdType="pubmed">38249443</ArticleId></ArticleIdList></Reference><Reference><Citation>Uhteg K, Amadi A, Forman M, Mostafa HH. 2022. Circulation of non-SARS-CoV-2 respiratory pathogens and coinfection with SARS-CoV-2 amid the COVID-19 pandemic. Open Forum Infect Dis 9:ofab618. doi:10.1093/ofid/ofab618</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofab618</ArticleId><ArticleId IdType="pmc">PMC8863080</ArticleId><ArticleId IdType="pubmed">35211632</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanson KE, Azar MM, Banerjee R, Chou A, Colgrove RC, Ginocchio CC, Hayden MK, Holodiny M, Jain S, Koo S, Levy J, Timbrook TT, Caliendo AM. 2020. Molecular testing for acute respiratory tract infections: clinical and diagnostic recommendations from the IDSA’s diagnostics committee. Clin Infect Dis 71:2744–2751. doi:10.1093/cid/ciaa508</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa508</ArticleId><ArticleId IdType="pmc">PMC7454374</ArticleId><ArticleId IdType="pubmed">32369578</ArticleId></ArticleIdList></Reference><Reference><Citation>Moriyama M, Hugentobler WJ, Iwasaki A. 2020. Seasonality of respiratory viral infections. Annu Rev Virol 7:83–101. doi:10.1146/annurev-virology-012420-022445</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-virology-012420-022445</ArticleId><ArticleId IdType="pubmed">32196426</ArticleId></ArticleIdList></Reference><Reference><Citation>Tamerius J, Nelson MI, Zhou SZ, Viboud C, Miller MA, Alonso WJ. 2011. Global influenza seasonality: reconciling patterns across temperate and tropical regions. Environ Health Perspect 119:439–445. doi:10.1289/ehp.1002383</Citation><ArticleIdList><ArticleId IdType="doi">10.1289/ehp.1002383</ArticleId><ArticleId IdType="pmc">PMC3080923</ArticleId><ArticleId IdType="pubmed">21097384</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamid S, Winn A, Parikh R, Jones JM, McMorrow M, Prill MM, Silk BJ, Scobie HM, Hall AJ. 2023. Seasonality of respiratory syncytial virus - United States, 2017-2023. MMWR Morb Mortal Wkly Rep 72:355–361. doi:10.15585/mmwr.mm7214a1</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm7214a1</ArticleId><ArticleId IdType="pmc">PMC10078848</ArticleId><ArticleId IdType="pubmed">37022977</ArticleId></ArticleIdList></Reference><Reference><Citation>Cantú-Flores K, Rivera-Alfaro G, Muñoz-Escalante JC, Noyola DE. 2022. Global distribution of respiratory syncytial virus A and B infections: a systematic review. Pathog Glob Health 116:398–409. doi:10.1080/20477724.2022.2038053</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/20477724.2022.2038053</ArticleId><ArticleId IdType="pmc">PMC9518599</ArticleId><ArticleId IdType="pubmed">35156555</ArticleId></ArticleIdList></Reference><Reference><Citation>Fall A, Gallagher N, Morris CP, Norton JM, Pekosz A, Klein E, Mostafa HH. 2022. Circulation of enterovirus D68 during period of increased influenza-like Illness, Maryland, USA, 2021. Emerg Infect Dis 28:1525–1527. doi:10.3201/eid2807.212603</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid2807.212603</ArticleId><ArticleId IdType="pmc">PMC9239864</ArticleId><ArticleId IdType="pubmed">35642471</ArticleId></ArticleIdList></Reference><Reference><Citation>Fall A, Han L, Abdullah O, Norton JM, Eldesouki RE, Forman M, Morris CP, Klein EY, Mostafa HH. 2023. An increase in enterovirus D68 circulation and viral evolution during a period of increased influenza like illness, the Johns hopkins health system, USA, 2022. J Clin Virol 160:105379. doi:10.1016/j.jcv.2023.105379</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcv.2023.105379</ArticleId><ArticleId IdType="pubmed">36652754</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>